CoChat

The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice

Open access
Rennel, E S, Waine, E, Guan, H, Schüler, Y, Leenders, W, Woolard, J, Sugiono, M, Gillatt, D, Kleinerman, E S, Bates, D O, Harper, S J · 2008 · British Journal of Cancer
Cited by 124

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Vascular endothelial growth factor-A is widely regarded as the principal stimulator of angiogenesis required for tumour growth. VEGF is generated as multiple isoforms of two families, the pro-angiogenic family generated by proximal splice site selection in the terminal exon, termed VEGFxxx, and the anti-angiogenic family formed by distal splice site selection in the terminal exon, termed VEGFxxxb, where xxx is the amino acid number. The most studied isoforms, VEGF165 and VEGF165b have been shown to be present in tumour and normal tissues respectively. VEGF165b has been shown to inhibit VEGF- and hypoxia-induced angiogenesis, and VEGF-induced cell migration and proliferation in vitro. Here we show that overexpression of VEGF165b by tumour cells inhibits the growth of prostate carcinoma, Ewing's sarcoma and renal cell carcinoma in xenografted mouse tumour models. Moreover, VEGF165b overexpression inhibited tumour cell-mediated migration and proliferation of endothelial cells. These data show that overexpression of VEGF165b can inhibit growth of multiple tumour types in vivo indicating that VEGF165b has potential as an anti-angiogenic, anti-tumour strategy in a number of different tumour types, either by control of VEGF165b expression by regulation of splicing, overexpression of VEGF165b, or therapeutic delivery of VEGF165b to tumours.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjc.6604309

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 124

Metadata

Authors
Rennel, E. S., Waine, E., Guan, H., Schüler, Y., Leenders, W., Woolard, J., Sugiono, M., Gillatt, D., Kleinerman, E. S., Bates, D. O., & Harper, S. J.
Venue
British Journal of Cancer
Published
2008-03-18
Volume
98
Issue
7
Pages
1250-1257
ISSN
  • 0007-0920 (ISSN-L)
  • 1532-1827
OpenAlex
W2065863629
Cited by
124
References
3
FWCI
5.34
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice. https://app.cochat.ai/papers/10.1038/sj.bjc.6604309
The paper
Rennel, E. S., Waine, E., Guan, H., Schüler, Y., Leenders, W., Woolard, J., Sugiono, M., Gillatt, D., Kleinerman, E. S., Bates, D. O., & Harper, S. J. (2008). The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice. British Journal of Cancer. https://doi.org/10.1038/sj.bjc.6604309

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.